IP Library Granted Patent US 10,272,260
Granted Patent B2
US 10,272,260 · App. 14/286,689 · Granted Apr 30, 2019

Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,272,260
App. No.
14/286,689
Granted
Apr 30, 2019
Kind
B2
Abstract

Methods and devices for diagnosing, monitoring, and/or treating tissue through an opening or port through an airway wall. A passageway is created extending from the airway to the target tissue. The passageway provides local access to the target tissue for treatment instruments and for delivering agents.

Claims (32)

1. A method of treating a target tissue in a parenchymal tissue of a lung of a patient, the method comprising:

locating a target site on an airway wall;

creating an opening through the airway wall at the target site;

advancing an elongate instrument through the opening to the target tissue, said elongate instrument comprising an access lumen;

advancing a light delivery instrument through the access lumen and through the opening into the parenchyma to the target tissue in the parenchymal tissue of the lung;

administering a photosensitive drug to the patient; and

directing a beam of light locally at the target tissue, while minimizing collateral damage to surrounding tissue, such that the light activates the photosensitive drug at the target tissue.

2. The method of claim 1 wherein the step of administering is carried out locally to the target tissue.

3. The method of claim 2 wherein the step of administering is carried out by advancing a delivery catheter through the access lumen of the elongate instrument and transporting the photosensitive drug to the target site through the delivery catheter.

4. The method of claim 1 wherein the step of administering is carried out by intravenous injection.

5. The method of claim 1 , further comprising dilating the opening with an expandable member.

6. The method of claim 1 , wherein advancing the elongate instrument comprises advancing the elongate instrument and a blunt tipped dissecting catheter positioned within the elongate instrument through the opening and to the target tissue.

7. The method of claim 1 , further comprising performing imaging to guide the elongate instrument to the target tissue.

8. The method of claim 1 , wherein the step of directing the beam of light comprises forming a singlet oxygen molecule by applying a specific wavelength of light to the target tissue, destroying the target tissue from the inside out.

9. The method of claim 1 , wherein the elongate instrument is a needle.

10. The method of claim 1 , wherein the light delivery instrument is retractable to increase its field of view.

11. The method of claim 1 , wherein a lens at the tip of the light instrument is interchangeable for a diffuse beam lens.

12. A method of treating a target tissue within a parenchyma in a lung of a patient, the method comprising:

locating a target site on an airway wall;

creating an opening through the airway wall at the target site;

advancing an elongate instrument through the opening to the target within the parenchyma, said elongate instrument comprising an access lumen;

advancing a delivery catheter through the access lumen;

administering a photosensitive drug to the target tissue through the delivery catheter; and

directing a beam of light to the target tissue while minimizing collateral damage to surrounding tissue, such that the light activates the photosensitive drug at the target tissue within the parenchyma.

13. The method of claim 12 further comprising activating the photosensitive drug to destroy the target tissue.

14. The method of claim 12 further comprising advancing a light delivery instrument through the access lumen to the target tissue.

15. The method of claim 14 wherein activating the photosensitive drug at the target tissue is carried out with the light delivery instrument locally positioned at the target tissue.

16. The method of claim 12 wherein the piercing member comprises an elongate flexible body, a distal section carrying an expandable balloon, and a sharp distal tip.

17. The method of claim 16 further comprising dilating the opening with the balloon.

18. The method of claim 12 , wherein the step of directing the narrow beam of light comprises forming a singlet oxygen molecule by applying a specific wavelength of light to the target tissue, destroying the target tissue from the inside out.

19. The method of claim 12 , wherein the light delivery instrument is retractable to increase its field of view.

20. The method of claim 12 , wherein a lens at the tip of the light instrument is interchangeable for a diffuse beam lens.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2014
From: LAUFER, MICHAEL D.; KAPLAN, GARY S.; KEAST, THOMAS M.; COLE, CARY; WIBOWO, HENKY; ROSCHAK, EDMUND J.
To: BRONCUS TECHNOLOGIES, INC.
Reel/Frame 033458/0897 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2014
From: BRONCUS TECHNOLOGIES, INC.
To: BRONCUS MEDICAL INC.
Reel/Frame 033458/0941 →
Cited By (3)
US 12,433,578 US 12,544,086 US 12,667,350